Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.129, Iss.3, 2011-10, pp. : 867-875

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MRI in patients with axillary metastases of occult breast carcinoma

By Tilanus-Linthorst M.M.A. Obdeijn A.I.M. Bontenbal M. Oudkerk a.M.

Breast Cancer Research and Treatment, Vol. 44, Iss. 2, 1997-06 ,pp. : 178-182

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes

By Nelli Fabrizio

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 343-349

Springer Publishing Company

Access to resources Recommend Favorite

Axillary Metastases of an Occult Primary Carcinoma of the Breast-Discovered Only by 99m Tc-Tetrofosmin Scintigraphy

By Obwegeser R. Obruca A. Auerbach L. Kubista E. Sinzinger H.

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 418-420

Elsevier

Access to resources Recommend Favorite

Clinical experience with axillary presentation breast cancer

By Galimberti Viviana

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Statistical kinematics of axillary nodal metastases in breast carcinoma

By Kendal Wayne

Clinical and Experimental Metastasis, Vol. 22, Iss. 2, 2005-04 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite